CORD-19:0049ba8861864506e1e8559e7815f4de8b03dbed / 33872-34197 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/0049ba8861864506e1e8559e7815f4de8b03dbed","sourcedb":"CORD-19","sourceid":"0049ba8861864506e1e8559e7815f4de8b03dbed","text":"The packaging cell line 293T was purchased from Invitrogen Life Technologies (San Diego, CA) and maintained in complete DMEM medium [i.e. high glucose DMEM supplemented with 10% FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, penicillin (100 U/ml), streptomycin (100 μg/ml)] plus G418 (500 μg/ml) (Invitrogen Life Technologies).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T201","span":{"begin":0,"end":325},"obj":"Sentence"},{"id":"T51355","span":{"begin":0,"end":325},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T201","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T51355","pred":"source","obj":"CORD-19-Sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec939d","default":true}]}]}}